Natera Inc
(NAS:NTRA)
$
162.39
0.4 (0.25%)
Market Cap: 21.44 Bil
Enterprise Value: 20.99 Bil
PE Ratio: 0
PB Ratio: 22.95
GF Score: 70/100 Natera Inc at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023 / 09:40PM GMT
Release Date Price:
$50.72
(+2.53%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
All right, everybody. Thank you very much for joining this afternoon. I'm Matt Sykes, the Life Science Tools and Diagnostics Analyst at Goldman Sachs. I have the pleasure welcoming the management team from Natera today, Steve Chapman, CEO; and Mike Brophy, CFO. Steve, Mike, thanks very much for joining us today.
Steven Leonard Chapman
Natera, Inc. - CEO, President & Director
Thanks, Matt.
Michael B. Brophy
Natera, Inc. - CFO
Thanks for having us.
Questions & Answers
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Maybe -- if you could maybe help set the stage first, talk about the most recent results, kind of some of the trends you're seeing in the business, what to expect for '23? And maybe sort of -- for those who might be new to the story, just a brief summary of the business model and some of the main areas where you're
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot